Vaxinano

Vaxinano develops a nasal vaccine platform called Stellar-NP, which utilizes an advanced antigen delivery technology to enhance immune responses. The company focuses on prophylactic and therapeutic vaccines targeting fungi, parasites, viruses, and bacteria in both human and veterinary medicine. Their applications include protecting livestock and endangered species in zoos against infectious diseases like toxoplasmosis.